ZMD.H — ZoomMed Income Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual income statement for ZoomMed, fiscal year end - May 31st, CAD millions except per share, conversion factor applied.
R2015 May 31st | 2016 May 31st | 2017 May 31st | 2022 May 31st | 2023 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0.011 | 0.452 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2.4 | 1.66 | 2 | 1.24 | 0.276 |
| Operating Profit | -2.4 | -1.66 | -2 | -1.23 | 0.175 |
| Net Income Before Taxes | -2.4 | -1.66 | -2 | -1.23 | 0.175 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.68 | -1.42 | -2 | -1.23 | 0.175 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 3.76 | -0.95 | -2.12 | -1.23 | 0.175 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.76 | -0.95 | -2.12 | -1.23 | 0.175 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.008 | -0.01 | -0.014 | -0.009 | 0.001 |